v3.26.1
STOCKHOLDERS' DEFICIT (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share-based compensation expense by award type:

(In thousands)Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
RSUs$5,408 $4,017 $8,530 $9,345 
Performance RSUs13,530 3,217 10,767 6,746 
Options— 26 — 198 
Total Share-Based Compensation Expense(1)
$18,938 $7,260 $19,297 $16,289 
(1)Total share-based compensation expense includes $13.7 million and $10.4 million of expense from cash-settled awards for the three and six months ended June 30, 2026, respectively. Total share-based compensation expense includes $2.6 million and $4.2 million of expense from cash-settled awards for the three and six months ended June 30, 2025, respectively. The increase in share-based compensation recognized in 2026 is due to changes in the Company’s stock price, resulting in higher expense associated with cash-settled awards.
Schedule of Computation of Loss per Share
Computation of Loss per Share
(In thousands, except per share data)Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
NUMERATOR:
Net loss attributable to the Company – common shares$(82,389)$(83,480)$(177,612)$(364,704)
DENOMINATOR(1):
Weighted average common shares outstanding - basic157,707 154,275 156,753 153,382 
  Stock options and restricted stock(2):
— — — — 
Weighted average common shares outstanding - diluted157,707 154,275 156,753 153,382 
Net loss attributable to the Company per common share:
Basic$(0.52)$(0.54)$(1.13)$(2.38)
Diluted(0.52)(0.54)(1.13)(2.38)
(1)All of the outstanding Class B common stock and Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three and six months ended June 30, 2026 and 2025.
(2)Outstanding equity service awards representing 12.2 million and 12.6 million shares of Class A common stock of the Company for the three months ended June 30, 2026 and 2025, respectively, and 12.6 million and 14.6 million shares of Class A common stock for the six months ended June 30, 2026 and 2025, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.